Good morning, Coastal Bend! Here's a look at the 6 things you need to know before you walk out the door this Friday morning.

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...